Forvis Mazars Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.69M | Sell |
|
|||||
|
2025
Q2 | $1.71M | Sell |
|
|||||
|
2025
Q1 | $2.15M | Buy |
|
|||||
|
2024
Q4 | $2.32M | Buy |
|
|||||
|
2024
Q3 | $3.38M | Sell |
|
|||||
|
2024
Q2 | $3.43M | Buy |
|
|||||
|
2024
Q1 | $3.12M | Sell |
|
|||||
|
2023
Q4 | $2.89M | Sell |
|
|||||
|
2023
Q3 | $2.84M | Sell |
|
|||||
|
2023
Q2 | $3.61M | Buy |
|
|||||
|
2023
Q1 | $2.99M | Buy |
|
|||||
|
2022
Q4 | $2.56M | Buy |
|
|||||
|
2022
Q3 | $2.43M | Buy |
|
|||||
|
2022
Q2 | $1.98M | Buy |
|
|||||
|
2022
Q1 | $2.18M | Buy |
|
|||||
|
2021
Q4 | $1.74M | Buy |
|
|||||
|
2021
Q3 | $1.41M | Buy |
|
|||||
|
2021
Q2 | $326K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $275K | Sell |
|
|||||
|
2020
Q1 | $487K | Buy |
|